Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 200-702, Republic of Korea.
Toxicology. 2010 Oct 29;276(3):192-7. doi: 10.1016/j.tox.2010.08.004. Epub 2010 Aug 13.
This study investigated the preventive effect of ribosomal protein S3 (rpS3) on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ear edema in mice. A cell permeable expression vector PEP-1-rpS3 was constructed. Topical application of the vector markedly inhibited TPA-induced expression levels of cyclooxygenase-2 (COX-2) and pro-inflammatory cytokines. Application of PEP-1-rpS3 also resulted in a significant reduction in the activation of nuclear factor-kappa B (NF-kB) and mitogen-activated protein kinase (MAPK) in TPA-treated ears. These results indicate that PEP-1-rpS3 inhibits inflammatory response cytokines and enzymes by blocking NF-kB and MAPK, prompting the suggestion that PEP-1-rpS3 can be used as a therapeutic agent against skin inflammation.
本研究探讨了核糖体蛋白 S3(rpS3)对 12-O-十四烷酰佛波醇-13-醋酸酯(TPA)诱导的小鼠耳水肿的预防作用。构建了一种细胞通透性表达载体 PEP-1-rpS3。该载体的局部应用显著抑制了 TPA 诱导的环氧合酶-2(COX-2)和促炎细胞因子的表达水平。PEP-1-rpS3 的应用也导致 TPA 处理的耳朵中核因子-κB(NF-κB)和丝裂原活化蛋白激酶(MAPK)的激活显著减少。这些结果表明,PEP-1-rpS3 通过阻断 NF-κB 和 MAPK 抑制炎症反应细胞因子和酶,提示 PEP-1-rpS3 可用作治疗皮肤炎症的药物。